Page last updated: 2024-11-02

phenobarbital and Congenital Infection, Toxoplasma gondii

phenobarbital has been researched along with Congenital Infection, Toxoplasma gondii in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McLeod, R1
Mack, D1
Foss, R1
Boyer, K1
Withers, S1
Levin, S1
Hubbell, J1

Other Studies

1 other study available for phenobarbital and Congenital Infection, Toxoplasma gondii

ArticleYear
Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:5

    Topics: Chromatography, High Pressure Liquid; Humans; Infant; Infant, Newborn; Leucovorin; Phenobarbital; Py

1992